# US 2008/0306090 A1 · Thiourea derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0306090 A1
- Document ID: US20080306090A1
- Status: Published application
- Kind: A1
- Application number: 12/115,221
- Filed: 2008-05-05
- Published: 2008-12-11
- Earliest claimed: 2007-06-08
- Assignees: National Health Research Institutes
- Inventors: Jyh-Haur Chern; Tsu-An Hsu; Iou-Jiun Kang; Li-Wen Wang; Chung-Chi Lee; Yen-Chun Lee; Yu-Sheng Chao
- Web page: https://patentgrep.com/patent/US20080306090A1

## CPC

- C07D 295/088: to an acyclic saturated chain
- A61P 31/12: Antivirals
- C07C 335/18: being further substituted by singly-bound oxygen atoms
- C07D 209/88: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D 215/38: Nitrogen atoms (nitro radicals C07D215/18)
- C07D 231/12: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D 295/12: substituted by singly or doubly bound nitrogen atoms (nitro radicals C07D295/06)
- C07D 307/91: Dibenzofurans; Hydrogenated dibenzofurans
- C07C 2601/14: The ring being saturated
- C07C 2602/08: the other ring being five-membered, e.g. indane
- C07C 2603/18: Fluorenes; Hydrogenated fluorenes
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

Thiourea compounds of the following formula: wherein n, R1, R2, R3, A1, A2, X, Y, and Z are defined herein. Also disclosed is a method of treating hepatitis C virus infection with these compounds.

## Claims

### Claim 1

A compound of formula (I):
wherein
n is 1-10;
R1 is H, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, C3-C20 cycloalkyl, C3-C20 cycloalkenyl, C3-C20 heterocycloalkyl, aryl, or heteroaryl;
each of R2 and R3, independently, is H, halo, nitro, cyano, amino, hydroxy, alkoxy, aryloxy, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, C3-C20 cycloalkyl, C3-C20 cycloalkenyl, C3-C20 heterocycloalkyl, aryl, or heteroaryl;
A1 is arylene or heteroarylene, optionally substituted with halo, nitro, cyano, amino, hydroxy, alkoxy, aryloxy, alkylcarbonyl, alkoxycarbonyl, carboxy, aminocarbonyl, carbonylamino, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, C3-C20 cycloalkyl, C3-C20 cycloalkenyl, C3-C20 heterocycloalkyl, aryl, or heteroaryl;
A2 is alkyl, clycloalkyl, heterocycloalkyl, aryl, or heteroaryl, in which alkyl is optionally substituted with halo, nitro, cyano, amino, hydroxy, alkoxy, aryloxy, alkylcarbonyl, alkoxycarbonyl, carboxy, aminocarbonyl, carbonylamino, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, C3-C20 cycloalkyl, C3-C20 cycloalkenyl, C3-C20 heterocycloalkyl, aryl, or heteroaryl; and each of clycloalkyl, heterocycloalkyl, aryl, and heteroaryl is optionally substituted with halo, nitro, cyano, amino, hydroxy, alkoxy, aryloxy, alkylcarbonyl, alkoxycarbonyl, carboxy, aminocarbonyl, carbonylamino, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, C3-C20 cycloalkyl, C3-C20 cycloalkenyl, C3-C20 heterocycloalkyl, aryl, or heteroaryl, or optionally fused with C3-C20 cycloalkyl, C3-C20 heterocycloalkyl, aryl, or heteroaryl;
each of X and Y, independently, is O, S, or N(Ra), in which Ra is H, C1-C10 alkyl, C3-C20 cycloalkyl, C3-C20 heterocycloalkyl, aryl, or heteroaryl; and
Z is —NHSO2—, —NHC(═O)—, —C(═O)NH—, —NHC(═O)O—, —NHC(═O)NH—, —NHC(═S)NH—, —NHC(═NH)NH—, C3-C20 cycloalkyl, or C3-C20 heterocycloalkyl.

### Claim 2 (depends on 1)

The compound of claim 1, wherein X is S.

### Claim 3 (depends on 2)

The compound of claim 2, wherein A1 is 1,3-phenylene or 1,4-phenylene.

### Claim 4 (depends on 3)

The compound of claim 3, wherein Y is O.

### Claim 5 (depends on 4)

The compound of claim 4, wherein Z is —NHC(═S)NH—, —NHSO2—, —NHC(═O)—, —C(═O)NH—, or

### Claim 6 (depends on 5)

The compound of claim 5, wherein n is 5, 6, 7, or 8.

### Claim 7 (depends on 6)

The compound of claim 6, wherein A2 is phenyl or naphthenyl optionally substituted with halo, alkoxy, aryloxy, C1-C10 alkyl, C3-C20 cycloalkyl, aryl, or heteroaryl.

### Claim 8 (depends on 6)

The compound of claim 6, wherein A2 is phenyl or naphthenyl fused with C3-C20 cycloalkyl, C3-C20 heterocycloalkyl, or heteroaryl.

### Claim 9 (depends on 2)

The compound of claim 2, wherein Z is —NHC(═S)NH—.

### Claim 10 (depends on 2)

The compound of claim 2, wherein Z is —NHSO2—, —NHC(═O)—, or —C(═O)NH—.

### Claim 11 (depends on 2)

The compound of claim 2, wherein Z is

### Claim 12 (depends on 1)

The compound of claim 1, wherein Y is O and Z is —NHC(═S)NH—.

### Claim 13 (depends on 1)

The compound of claim 1, wherein Y is O and Z is —NHSO2—, —NHC(═O)—, or —C(═O)NH—.

### Claim 14 (depends on 1)

The compound of claim 1, wherein Y is O and Z is

### Claim 15 (depends on 1)

The compound of claim 1, wherein A1 is 1,3-phenylene or 1,4-phenylene.

### Claim 16 (depends on 15)

The compound of claim 15, wherein A2 is phenyl or naphthenyl optionally substituted with halo, alkoxy, aryloxy, C1-C10 alkyl, C3-C20 cycloalkyl, aryl, or heteroaryl; or optionally fused with C3-C20 cycloalkyl, C3-C20 heterocycloalkyl, or heteroaryl.

### Claim 17 (depends on 1)

The compound of claim 1, wherein A2 is phenyl or naphthenyl optionally substituted with halo, alkoxy, aryloxy, C1-C10 alkyl, C3-C20 cycloalkyl, aryl, or heteroaryl.

### Claim 18 (depends on 1)

The compound of claim 1, wherein A2 is phenyl or naphthenyl fused with C3-C20 cycloalkyl, C3-C20 heterocycloalkyl, or heteroaryl.

### Claim 19 (depends on 16)

The compound of claim 16, wherein n is 5, 6, 7, or 8.

### Claim 20 (depends on 16)

The compound of claim 16, wherein Z is —NHC(═S)NH—.

### Claim 21 (depends on 16)

The compound of claim 16, wherein Z is —NHSO2—, —NHC(═O)—, or —C(═O)NH—.

### Claim 22 (depends on 1)

The compound of claim 1, wherein Z is

### Claim 23 (depends on 1)

The compound of claim 1, wherein the compound is one of Compounds 1-75.

### Claim 24 (depends on 1)

A method for treating hepatitis C virus infection, comprising administering to a subject in need thereof an effective amount of the compound of claim 1.

### Claim 25 (depends on 24)

The method of claim 24, wherein the compound is one of Compounds 1-75.
